Biotech Values

[rstor1]

AVGN

+++now, the resignation of the CFO+++

Funny, I thought of your hypothesis when I saw that.

+++Bob, are you sure aren’t being a sucker here?+++

Been one before, and I was pretty good at it. At the moment I have minimal $ in AVGN - a placeholder, for the most part - and the assets provide a bottom. If by the end of q1 the neuropathy molecule is still a mystery, I'll probably exit.

Regards,
Bob